Spectrum Sciences Patent-Pending Transdermal Microemulsion Technology

The scientific literature shows that B12 replacement therapy by intramuscular injection improves cognitive decline and fatigue symptoms in deficient patients, particularly when initiated early.

Despite the fact that clinical trials from which this data comes from rely on B12 injections specifically, many people still erroneously take that to mean a B12 deficiency can be fixed easily through B12 pills.

If oral B12 supplements could correct a long-standing B12 deficiency, this wouldn't be a worldwide problem.  The average US diet provides a daily intake of between 3.66 - 5.84 micrograms of vitamin B12, which is well above the 2.4 micrograms recommended by the NIH.

Clearly, there is a bigger problem than what a poorly-absorbed capsule or even a carnivorous diet can solve.

The reason injections are much more effective than capsules, in addition to the massive dose they supply, is due to the fact that oral administration of vitamin B12 is poorly absorbed.

We wish it were as simple as taking a daily capsule of vitamin B12 to replete the brain of this vital nutrient, but unfortunately, that is not the case.  Most of the vitamin B12 contained in capsules simply ends up in the toilet.

Create a realistic photograph of transparent capsules filled with crimson red powder floating in toilet water.

Vitamin B12 absorption in the GI tract is facilitated by a protein known as intrinsic factor, which acts as a shuttle from the gut to systemic circulation.  It has been shown that intrinsic factor is saturated around 10 micrograms, meaning oral absorption is limited to about 10 micrograms per feeding.  This falls far short of the dosages used in any of the replacement therapy protocols used by these teams of researchers.

In addition to the absorption problem, scientists also believe that there is significant benefit to sustained release of vitamin B12 into systemic circulation, which maintains elevated blood levels and optimizes intracellular absorption.

This is a big reason why most doctors who prescribe vitamin B12 replacement therapy for their patients initially prescribe smaller injection doses (~100 micrograms) on a daily basis for the first 1-2 weeks, followed by a gradual taper to monthly injections.

Continuing with daily injections would provide a greater benefit, but this comes at the risk of poor patient compliance.  The compromise is that doctors start their patient on a frequent injection regiment and then switch to less frequent injections so they continue to retain some of the benefits by not stopping treatment altogether.

But what if a person could enjoy the convenience of a daily, at-home supplement, and the power of a daily high-dose injection?

That is why we have developed patent-pending transdermal microemulsion technology, vastly improving vitamin B12 absorption compared to oral capsules and powders, allowing for an at-home option that provides doses used in a clinical setting.

Activated B12 Oil

This method also provides the benefits of slow release into systemic circulation, mimicking the results of daily injections without the hassle of prescriptions, needles, and insurance claim denials.

Activated B12 Oil readily penetrates through the deepest layers of the skin, delivering both active forms of Vitamin B12 into the blood stream.  Oral B12 supplements cannot compare.  This efficient and convenient delivery system helps to ensure compliance, consistency, and efficacy, encouraging a long-term commitment to better health.

How It Works

Studies show that microemulsions are a safe and effective way to deliver substances across the skin into systemic circulation.  The microemulsion particle must be small enough to diffuse into the upper layers of the skin and efficiently fill hair follicle canals, releasing their contents into circulation.  Smaller microemulsion particles result in more effective and deeper skin permeation due to their increased surface area to volume ratio, giving them the ability to bypass the skin barrier.  This makes topical application of the microemulsion a superior method for transdermal delivery.

 

Our team has meticulously developed and tested various formulations and proportions, crafting the most efficient microstructure, allowing these particles containing vitamin B12 to permeate the skin.

We are on a mission to improve health, so all ingredients we use are recognized as safe for sustained contact with the skin and are quickly metabolized and cleared by the body.

Spectrum Sciences Activated B12 Oil is a topical serum supplying the critical nutrient, Vitamin B12 in its two active forms, methylcobalamin and adenosylcobalamin. Methylcobalamin is needed to support the methylation cycle, while adenosylcobalamin is needed by the mitochondria for energy production.  Inclusion of the two active forms explains why our formula is a potent weapon against both age-related cognitive decline and fatigue.

Sustained systemic delivery mimics the pattern of daily injections without the hassles and costs associated with doctor's visits, needles, pharmacies and insurance companies.

That means you get not only a higher blood level of B12 but also a steadier blood level of B12 with transdermal application when compared to oral capsules.

As an Epoch Times reader, we would like to offer you 15% off your order for trying our Activated B12 Oil.  Normally priced at $35, enter code EPOCH15 at checkout and you pay only $29.75.  The code applies to your entire cart.

Protect your mind and body from age-related fatigue and cognitive decline with our Activated B12 Oil.  Only our technology can compete with injectable B12!


Proudly Made in the USA

Spectrum Sciences is committed to bringing the very best vitamin B12 supplement to the world. Our founder credits his son's recovery from autism to the power of B12 therapy.  He formed this company out of heartfelt inspiration to bring healing to the individuals and families who desperately need it.  Leveraging his credentials as a chemist, certified health coach, and most importantly as a father of a child whose early life was characterized by struggle but who now thrives, Spectrum Sciences was born.  Testimonials are from real customers of Spectrum Sciences Activated B12 Oil.  We look forward to hearing about your success story as well!

 

References

Boche M, Pokharkar V. (2020). Microemulsion assisted transdermal
delivery of a hydrophilic anti-osteoporotic drug: Formulation, in vivo
pharmacokinetic studies, in vitro cell osteogenic activity. Journal of
Applied Pharmaceutical Science, 10(08):008-019.

Boche M, Pokharkar V. (2020). Evaluating two nanocarrier systems
for the transdermal delivery of sodium alendronate: Microemulsions and
solid-in-oil nanosuspensions. International Journal of Pharmaceutics.

Yadav K, Soni G, Chaudhary D, Khanduri A, Bhandari A, Joshi G.
(2023). Microemulsions for Enhancing Drug Delivery of Hydrophilic Drugs:
Exploring Various Routes of Administration. Medicine in Drug Discovery,
18:100162.

Leporatti S, et al. (2023). Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery. Pharmaceutics, 15(5): 1292.

A Review on Microemulsion for Drug Delivery System. (2023). World Journal of Pharmaceutical and Medical Research, 9(5): 109-117.

Kumar S, et al. (2024). Strategies to Improve the Transdermal
Delivery of Poorly Water-Soluble NSAIDs. Pharmaceuticals, 17(5): 512.

Transdermal Drug Delivery System: A Comprehensive Review of
Strategies, Regulatory Requirements, and Recent Advances. (2025).
Journal of Drug Delivery Science and Technology, 85:104227.

Bae, CY., Piao, M., Kim, M. et al. Biological age and lifestyle in the diagnosis of metabolic syndrome: the NHIS health screening data, 2014–2015. Sci Rep 11, 444 (2021). https://doi.org/10.1038/s41598-020-79256-4

Hooshmand B, Refsum H, Smith AD, et al. Association of Methionine to Homocysteine Status With Brain Magnetic Resonance Imaging Measures and Risk of Dementia. JAMA Psychiatry. 2019;76(11):1198–1205. doi:10.1001/jamapsychiatry.2019.1694

 James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004 Dec;80(6):1611-7. doi: 10.1093/ajcn/80.6.1611. PMID: 15585776.

Rossignol DA, Frye RE. The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. J Pers Med. 2021 Aug 11;11(8):784. doi: 10.3390/jpm11080784. PMID: 34442428; PMCID: PMC8400809.

Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PLoS One. 2016 Jan 22;11(1):e0146797. doi: 10.1371/journal.pone.0146797. PMID: 26799654; PMCID: PMC4723262.

Li X, Feng X, Sun X, Hou N, Han F and Liu Y (2022) Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019. Front. Aging Neurosci. 14:937486. doi: 10.3389/fnagi.2022.937486

Fang, M., Hu, J., Weiss, J. et al. Lifetime risk and projected burden of dementia. Nat Med 31, 772–776 (2025). https://doi.org/10.1038/s41591-024-03340-9

Li Z, Yang Y, Liu Y, Wang X, Ping F, Xu L, Zhang H, Li W, Li Y. Global burden of dementia in younger people: an analysis of data from the 2021 Global Burden of Disease Study. EClinicalMedicine. 2024 Oct 3;77:102868. doi: 10.1016/j.eclinm.2024.102868. PMID: 39416391; PMCID: PMC11474392.

Jatoi S, Hafeez A, Riaz SU, Ali A, Ghauri MI, Zehra M. Low Vitamin B12 Levels: An Underestimated Cause Of Minimal Cognitive Impairment And Dementia. Cureus. 2020 Feb 13;12(2):e6976. doi: 10.7759/cureus.6976. PMID: 32206454; PMCID: PMC7077099.

Koralnik, Igor J., and Kenneth L. Tyler. "COVID‐19: A Global Threat to the Nervous System." Annals of Neurology, vol. 88, no. 1, 2020, pp. 1–11. Wiley Online Library, https://doi.org/10.1002/ana.27200.

Hooshmand, Babak, et al. "Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study." Neurology, vol. 75, no. 16, 2010, pp. 1408-1414. American Academy of Neurology, https://doi.org/10.1212/WNL.0b013e3181f88162.

AD.  2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30. PMID: 38689398; PMCID: PMC11095490.